Figure 3.

Effects of Lenalidomide on anti-dsDNA antibody and complement levels. Comparison of anti-dsDNA antibody titres (A) and complement levels (B) at baseline and after completing the course of treatment.

Cortés-Hernández et al. Arthritis Research & Therapy 2012 14:R265   doi:10.1186/ar4111
Download authors' original image